 <h1>Utibron Neohaler Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>glycopyrrolate / indacaterol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about glycopyrrolate / indacaterol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Utibron Neohaler.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to glycopyrrolate/indacaterol: inhalation capsule</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, glycopyrrolate / indacaterol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking glycopyrrolate / indacaterol:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>body aches or pain</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>difficulty in breathing</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>ear congestion</li>
<li>fever</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>loss of voice</li>
<li>nausea</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>runny or stuffy nose</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stomach pain</li>
<li>sweating</li>
<li>tightness in the chest</li>
<li>unexplained weight loss</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>decreased urination</li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>pain in the lower abdomen, groin, upper back, or sides</li>
<li>rapid weight gain</li>
<li>tingling of the hands or feet</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of glycopyrrolate / indacaterol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>diarrhea</li>
<li>fever</li>
<li>heartburn</li>
<li>mouth or throat pain</li>
<li>muscle aches</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Belching</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>stomach discomfort or upset</li>
<li>trouble sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Hoarseness</li>
<li>voice changes</li>
</ul><p>
<!-- end inhalation capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glycopyrrolate / indacaterol: inhalation capsule</i></p><h3>General</h3><p>The most common adverse reaction was nasopharyngitis and hypertension.  Cough was also common, but usually of mild intensity.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper and lower respiratory tract infection</p>
<p><b>Common</b> (1% to 10%): Nasopharyngitis (4.1%), oropharyngeal pain (1.6%), pneumonia, rhinitis, sinusitis, cough, throat irritation</p>
<p><b>Uncommon</b> (0.1% to 1%): Paradoxical bronchospasm, epistaxis</p>
<p><b>Very rare</b> (less than 0.01%): Chest pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastroesophageal reflux disease, dyspepsia, dental caries, gastroenteritis</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperglycemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Diabetes mellitus<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, musculoskeletal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscle spasm, myalgia, pain in extremity<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Paraesthesia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pyrexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Fatigue, peripheral edema<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hypertension (2%), ischemic heart disease, atrial fibrillation, tachycardia, palpitations</p>
<p><b>Very rare</b> (less than 0.01%): Atrial fibrillation, palpitations, tachycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Angioedema, rash, pruritus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Bladder obstruction, urinary retention<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Glaucoma<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Utibron Neohaler (glycopyrrolate-indacaterol (glycopyrronium-indacaterol))." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."  </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How do you use a Utibron Neohaler?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Utibron Neohaler (glycopyrrolate / indacaterol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Drug class: bronchodilator combinations</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Utibron Neohaler &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>COPD, Maintenance</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glycopyrrolate / indacaterol: inhalation capsule</i></p><h3>General</h3><p>The most common adverse reaction was nasopharyngitis and hypertension.  Cough was also common, but usually of mild intensity.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper and lower respiratory tract infection</p><p><b>Common</b> (1% to 10%): Nasopharyngitis (4.1%), oropharyngeal pain (1.6%), pneumonia, rhinitis, sinusitis, cough, throat irritation</p><p><b>Uncommon</b> (0.1% to 1%): Paradoxical bronchospasm, epistaxis</p><p><b>Very rare</b> (less than 0.01%): Chest pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastroesophageal reflux disease, dyspepsia, dental caries, gastroenteritis</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperglycemia</p><p><b>Uncommon</b> (0.1% to 1%): Diabetes mellitus<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, musculoskeletal pain</p><p><b>Uncommon</b> (0.1% to 1%): Muscle spasm, myalgia, pain in extremity<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Uncommon</b> (0.1% to 1%): Paraesthesia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pyrexia</p><p><b>Uncommon</b> (0.1% to 1%): Fatigue, peripheral edema<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hypertension (2%), ischemic heart disease, atrial fibrillation, tachycardia, palpitations</p><p><b>Very rare</b> (less than 0.01%): Atrial fibrillation, palpitations, tachycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Angioedema, rash, pruritus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Bladder obstruction, urinary retention<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Glaucoma<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Utibron Neohaler (glycopyrrolate-indacaterol (glycopyrronium-indacaterol))." Novartis Pharmaceuticals, East Hanover, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."  </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How do you use a Utibron Neohaler?</li>
</ul><h2>More about Utibron Neohaler (glycopyrrolate / indacaterol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Drug class: bronchodilator combinations</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Utibron Neohaler &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>COPD, Maintenance</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>